Global Peripheral Arterial Disease (PAD) Drugs Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3550362
- 83 Pages
- February 2020
- Healthcare
The global Peripheral Arterial Disease (PAD) Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Peripheral Arterial Disease (PAD) Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Peripheral Arterial Disease (PAD) Drugs Industry
Figure Peripheral Arterial Disease (PAD) Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Peripheral Arterial Disease (PAD) Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Peripheral Arterial Disease (PAD) Drugs
1.2.2 Downstream
Table Application Segment of Peripheral Arterial Disease (PAD) Drugs
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Peripheral Arterial Disease (PAD) Drugs Market by Type
3.1 By Type
3.1.1 Clopidogrel (Plavix)
Table Major Company List of Clopidogrel (Plavix)
3.1.2 Prasugrel (Effient)
Table Major Company List of Prasugrel (Effient)
3.1.3 Ticagrelor (Brilinta)
Table Major Company List of Ticagrelor (Brilinta)
3.1.4 Vorapaxar (Zontivity)
Table Major Company List of Vorapaxar (Zontivity)
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Type, in USD Million
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Type, in Volume
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 AstraZeneca Plc. (UK) (Company Profile, Sales Data etc.)
4.1.1 AstraZeneca Plc. (UK) Profile
Table AstraZeneca Plc. (UK) Overview List
4.1.2 AstraZeneca Plc. (UK) Products & Services
4.1.3 AstraZeneca Plc. (UK) Business Operation Conditions
Table Business Operation of AstraZeneca Plc. (UK) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bayer HealthCare Pharmaceuticals (Germany) (Company Profile, Sales Data etc.)
4.2.1 Bayer HealthCare Pharmaceuticals (Germany) Profile
Table Bayer HealthCare Pharmaceuticals (Germany) Overview List
4.2.2 Bayer HealthCare Pharmaceuticals (Germany) Products & Services
4.2.3 Bayer HealthCare Pharmaceuticals (Germany) Business Operation Conditions
Table Business Operation of Bayer HealthCare Pharmaceuticals (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bristol-Myers Squibb Company (US) (Company Profile, Sales Data etc.)
4.3.1 Bristol-Myers Squibb Company (US) Profile
Table Bristol-Myers Squibb Company (US) Overview List
4.3.2 Bristol-Myers Squibb Company (US) Products & Services
4.3.3 Bristol-Myers Squibb Company (US) Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Merck & Co., Inc. (US) (Company Profile, Sales Data etc.)
4.4.1 Merck & Co., Inc. (US) Profile
Table Merck & Co., Inc. (US) Overview List
4.4.2 Merck & Co., Inc. (US) Products & Services
4.4.3 Merck & Co., Inc. (US) Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Proteon Therapeutics, Inc. (US) (Company Profile, Sales Data etc.)
4.5.1 Proteon Therapeutics, Inc. (US) Profile
Table Proteon Therapeutics, Inc. (US) Overview List
4.5.2 Proteon Therapeutics, Inc. (US) Products & Services
4.5.3 Proteon Therapeutics, Inc. (US) Business Operation Conditions
Table Business Operation of Proteon Therapeutics, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sanofi S.A. (France) (Company Profile, Sales Data etc.)
4.6.1 Sanofi S.A. (France) Profile
Table Sanofi S.A. (France) Overview List
4.6.2 Sanofi S.A. (France) Products & Services
4.6.3 Sanofi S.A. (France) Business Operation Conditions
Table Business Operation of Sanofi S.A. (France) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Symic Bio, Inc. (US) (Company Profile, Sales Data etc.)
4.7.1 Symic Bio, Inc. (US) Profile
Table Symic Bio, Inc. (US) Overview List
4.7.2 Symic Bio, Inc. (US) Products & Services
4.7.3 Symic Bio, Inc. (US) Business Operation Conditions
Table Business Operation of Symic Bio, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 TheraVasc Inc. (US) (Company Profile, Sales Data etc.)
4.8.1 TheraVasc Inc. (US) Profile
Table TheraVasc Inc. (US) Overview List
4.8.2 TheraVasc Inc. (US) Products & Services
4.8.3 TheraVasc Inc. (US) Business Operation Conditions
Table Business Operation of TheraVasc Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Peripheral Arterial Disease (PAD) Drugs Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Concentration, in 2019
Figure Europe Peripheral Arterial Disease (PAD) Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Peripheral Arterial Disease (PAD) Drugs MMarket Concentration, in 2019
Figure South America Peripheral Arterial Disease (PAD) Drugs Market Concentration, in 2019
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Peripheral Arterial Disease (PAD) Drugs Demand in Hospitals, 2015-2019, in USD Million
Figure Peripheral Arterial Disease (PAD) Drugs Demand in Hospitals, 2015-2019, in Volume
6.1.2 Demand in Clinics
Figure Peripheral Arterial Disease (PAD) Drugs Demand in Clinics, 2015-2019, in USD Million
Figure Peripheral Arterial Disease (PAD) Drugs Demand in Clinics, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Peripheral Arterial Disease (PAD) Drugs Demand in Others, 2015-2019, in USD Million
Figure Peripheral Arterial Disease (PAD) Drugs Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Peripheral Arterial Disease (PAD) Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure Peripheral Arterial Disease (PAD) Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Peripheral Arterial Disease (PAD) Drugs Market Share in 2025, by Application, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Market Growth 2020-2025, by Application, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Peripheral Arterial Disease (PAD) Drugs Production 2015-2019, by Region, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Region, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Region, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Peripheral Arterial Disease (PAD) Drugs
Table Application Segment of Peripheral Arterial Disease (PAD) Drugs
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2025, by Application, in USD Million
Table Major Company List of Prasugrel (Effient)
Table Major Company List of Ticagrelor (Brilinta)
Table Major Company List of Vorapaxar (Zontivity)
Table Major Company List of Others
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Type, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Type, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Type, in Volume
Table AstraZeneca Plc. (UK) Overview List
Table Business Operation of AstraZeneca Plc. (UK) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Pharmaceuticals (Germany) Overview List
Table Business Operation of Bayer HealthCare Pharmaceuticals (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company (US) Overview List
Table Business Operation of Bristol-Myers Squibb Company (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. (US) Overview List
Table Business Operation of Merck & Co., Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Proteon Therapeutics, Inc. (US) Overview List
Table Business Operation of Proteon Therapeutics, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. (France) Overview List
Table Business Operation of Sanofi S.A. (France) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Symic Bio, Inc. (US) Overview List
Table Business Operation of Symic Bio, Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TheraVasc Inc. (US) Overview List
Table Business Operation of TheraVasc Inc. (US) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Peripheral Arterial Disease (PAD) Drugs Demand Forecast 2020-2025, by Application, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Market Growth 2020-2025, by Application, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Market Share in 2025, by Application, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Production 2015-2019, by Region, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Production 2015-2019, by Region, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Region, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Peripheral Arterial Disease (PAD) Drugs Market 2015-2019, by Region, in Volume
Table Global Peripheral Arterial Disease (PAD) Drugs Market Share 2015-2019, by Region, in Volume
Table North America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
Table Europe Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
Table South America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size 2015-2019, by Country, in Volume
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Peripheral Arterial Disease (PAD) Drugs Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
